Nick Leschly, President and CEO at 2seventy bio, Inc. (TSVT), sold 18,120 shares at $6.13 ($111K) on 2023-08-03, disclosed to the SEC on 2023-08-07.
Scheduled sale ($111k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.13 | 9,060 | $56K | 50.0% |
| 2 | $6.13 | 9,060 | $56K | 50.0% |
| Total | $6.13 avg | 18,120 | $111K | 100% |
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-01-18 | $22K | — | Filing → |